Resultados de la búsqueda 101-110 de 3925 para anti-TNF drugs

  1. Medicamentos para la COVID-19: ¿hay alguno que sea eficaz? - Mayo Clinic

    Mayo Clinic Proceedings. 2020; doi:10.1016/j.mayocp.2020.03.024. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. https ...

  2. Medicina de emergencia - Ensayos clínicos - Mayo Clinic

    ... Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of ...

  3. Untitled

    Page 1.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...

  5. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

  6. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

  7. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    ... therapy. Mayo Clinic Cancer Center Neuro-Oncology Program Registry and Biobank for the Study of Nervous System Tumors. Rochester, Minn. Biospecimen banks are ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to test drug enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC) ...

  9. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to test drug enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC) ...